Search
for
Sort by
Research 391–420 of 1000+
- Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- The therapeutic, diagnostic, and prognostic values of extracellular vesicles (exosomes) in dermatology: A systematic review
- A Case of Valproate Toxicity Related to Isoniazid
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Pharmaceutical care in transplantation: current challenges and future opportunities
- Menopause and hair loss in women: Exploring the hormonal transition
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- Migraine and the menopause transition
- Analysis of Common Treatment Drugs and Allergen Sensitization in Hair Loss Patients
- Evaluation of the Hair Growth-Promoting Effects of Combined Treatment with Hair Growth Stimulants
- Update on Platelet-Rich Plasma and Platelet-Rich Fibrin for Dermatologic Surgery: Addressing Knowns and Unknowns
- Anti-androgenetic effect of diphlorethohydroxycarmalol on testosterone-induced hair loss by inhibiting 5α-reductase and promoting Wnt/β-catenin signaling pathway in human dermal papilla cells
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Nanocarriers as Active Ingredients Enhancers in the Cosmetic Industry—The European and North America Regulation Challenges
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Linagliptin-Associated Alopecia and Bullous Pemphigoid
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Practices, Efficacy, and Reported Side Effects Associated with Isotretinoin Treatment in Palestine
- Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride
- Annual Convention in the Time of COVID
- The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?
- Breast implant illness: a topic in review
- Consensus position statement on emerging treatments in dermatology by the Association of Cutaneous Surgeons of India Task Force
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Hair Loss in Children, Etiologies, and Treatment
- Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines